5'-palmitoyl cytarabine has been researched along with Malignant Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, K; Naganuma, K; Sakurai, Y; Tsukagoshi, S; Tsuruo, T | 1 |
| Hartmann, HR; Hengartner, H; Rubas, W; Schott, H; Schwendener, R; Supersaxo, A; Weder, HG | 1 |
2 other study(ies) available for 5'-palmitoyl cytarabine and Malignant Melanoma
| Article | Year |
|---|---|
Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
Topics: Adenocarcinoma; Administration, Oral; Animals; Colonic Neoplasms; Cytarabine; Drug Evaluation, Preclinical; Leukemia L1210; Leukemia P388; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Neoplasms, Experimental | 1984 |
Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes.
Topics: Animals; Bone Marrow; Cytarabine; Female; Leukemia L1210; Liposomes; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA | 1986 |